Search results
Ayala Pharmaceuticals (NASDAQ:ADXS) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Wednesday morning. The firm issued a sell rating on the ...
LADENBURG THALM/SH SH Downgrades Coeptis Therapeutics (NASDAQ:COEP) to Hold
ETF DAILY NEWS· 3 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) was downgraded by equities research analysts at LADENBURG THALM/SH SH from a “strong-buy” rating to a “hold” rating in a research note issued ...
Canadian Sikhs thought they were safe to protest against India. Then one of them was gunned down
The Economist· 3 days agoSingh, who had served on the temple’s executive committee for over 15 years and was revered by the...
3,865 Shares in Incyte Co. (NASDAQ:INCY) Purchased by Syon Capital LLC
ETF DAILY NEWS· 6 days agoSyon Capital LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission ...
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 7 days agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 4,340,000 shares ...
Cullinan Therapeutics (NASDAQ:CGEM) Shares Gap Down to $18.88
ETF DAILY NEWS· 6 days agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) shares gapped down prior to trading on Monday . Cullinan Therapeutics shares last traded at $18.56, with a volume of 60,955 shares ...
Incyte (NASDAQ:INCY) Earns Neutral Rating from Cantor Fitzgerald
ETF DAILY NEWS· 5 days agoIncyte (NASDAQ:INCY – Get Free Report)‘s stock had its “neutral” rating restated by research analysts at Cantor Fitzgerald in a research note issued on Tuesday, Benzinga reports. A number of ...
Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM...
FOX 23 News Albany· 7 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it ...